Texas Pharmaceuticals Private Limited

Texas Pharmaceuticals Private Limited - pharma in Karnal, Haryana, India. FY 2026 financials & compliance.
CIN U24232HR2011PTC043450 Incorporated 19 July 2011 ROC Delhi HQ Karnal, Haryana, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹11.03 Cr
▲ 3% YoY
Net profit · FY 2025
₹6.29 Lakh
Net margin 0.6%
EBITDA · FY 2025
₹41.98 Lakh
EBITDA margin 3.8%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹86 Lakh
Issued & subscribed
Open charges
₹3.56 Cr
Satisfied ₹1.98 Cr
Company age
15 yrs
Est. 2011
Directors on board
4
As per MCA filings

About Texas Pharmaceuticals Private Limited

Data last updated:

Texas Pharmaceuticals Private Limited is a private limited company based in Karnal, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 July 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232HR2011PTC043450. Its GSTIN is 06AADCT9364J1ZW (Haryana).

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹86 Lakh. It was formerly known as Vivimed Pharmaceuticals Private Limited. It is led by directors including Madhu and Ashok Kumar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #87 Basement Dayal Singh Colony Karnal, Haryana, India – 132001.

As per the financials filed for FY 2025, the company reported a revenue of ₹11.03 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹6.29 Lakh (net margin 0.6%) and EBITDA of ₹41.98 Lakh (EBITDA margin 3.8%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 3% over five years.

As per MCA filings, the company has open charges of ₹3.56 Cr and satisfied charges of ₹1.98 Cr on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it; 2 cases are pending.

Texas Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-10-0001514). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website texasusa.in.

Company Details of Texas Pharmaceuticals Private Limited
CIN U24232HR2011PTC043450
Registration Number 043450
Incorporation Date 19 July 2011
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HR-10-0001514

Recognitions & Rankings of Texas Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-HR-10-0001514
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    #87 Basement Dayal Singh Colony Karnal, Haryana, India – 132001
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Texas Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Texas Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Texas Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Texas Pharmaceuticals Private Limited

The main business activity of Texas Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Texas Pharmaceuticals Private Limited FY 2025 filings available

Texas Pharmaceuticals Private Limited reported revenue of ₹11.03 Cr (up 3% YoY) for FY 2025.

Revenue · FY 2025
₹11.03 Cr ▲ 3%
Net profit · FY 2025
₹6.29 Lakh margin 0.6%
EBITDA · FY 2025
₹41.98 Lakh margin 3.8%

Compounded Annual Growth Rate (CAGR) of Texas Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▼ 3%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▲ 56%
3 years · compounded
▲ 2%
5 years · compounded
▼ 4%

Revenue rose 3% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 56% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Texas Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹41.98 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹6.29 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Texas Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin3.8%••••••••••••••••
Net Profit Margin0.6%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Texas Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Texas Pharmaceuticals Private Limited

Texas Pharmaceuticals has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
MadhuDirector16 Dec 201114 Years 10 MonthsCurrent
Ashok KumarDirector08 Aug 201412 Years 2 MonthsCurrent
Arvind MannDirector08 Aug 201412 Years 2 MonthsCurrent
Sachin GargDirector19 Jul 201115 Years 3 MonthsCurrent

Peer Comparison of Texas Pharmaceuticals Private Limited

Texas Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
RN Chemicals & Pharmaceutical Private Limited₹11.08 Cr (FY 2025)••••••••970.0%••••Solan, Himachal Pradesh, India
Pilco Healthcare Private Limited₹11.07 Cr (FY 2024)••••••••8.0%••••Kanpur, Uttar Pradesh, India
Osper Formulations Private Limited₹11.03 Cr (FY 2025)••••••••11.0%••••Rohtak, Haryana, India
Gryff Pharmaceuticals Private Limited₹11.03 Cr (FY 2024)••••••••17.0%••••Lucknow, Uttar Pradesh, India
Cisen Pharmaceuticals India Private Limited₹11.03 Cr (FY 2025)••••••••-22.0%••••Salcette, Goa, India
Texas Pharmaceuticals Private Limited this company₹11.03 Cr (FY 2025)••••••••3.0%••••Karnal, Haryana, India
Vignesh Life Sciences Pvt Ltd₹11.02 Cr (FY 2025)••••••••-14.0%••••Hyderabad, Telangana, India
Alenvision Pharma Private Limited₹11.01 Cr (FY 2025)••••••••11.0%••••Mumbai, Maharashtra, India
Eastern Chemical Industrias Pvt Ltd₹11 Cr (FY 2025)••••••••3.0%••••Cuttack, Odisha, India
Nav2dx Medicare Private Limited₹11 Cr (FY 2025)••••••••32.0%••••New Delhi, Delhi, India
Nivoxaa Biotech India Private Limited₹10.97 Cr (FY 2024)••••••••37.0%••••Karnal, Haryana, India

Peers are the five companies nearest above and the five nearest below Texas Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Texas Pharmaceuticals Private Limited

Texas Pharmaceuticals Private Limited is audited by ANIRUDH JINDAL & CO. for the financial year 2023.

NameStatusAppointment DateCessation Date
ANIRUDH JINDAL & CO.LockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Texas Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Texas Pharmaceuticals Private Limited

Open charges
₹3.56 Cr
Satisfied charges
₹1.98 Cr
Breakdown by lending institutions
Canara Bank₹3.56 Cr
Latest charge details
DateLenderAmountStatus
25 Aug 2025Canara Bank₹46 LakhOpen
11 Feb 2025Canara Bank₹60 LakhOpen
08 Mar 2013Canara Bank₹2.5 CrOpen
03 Aug 2023Canara Bank₹13 LakhSatisfied
18 Nov 2016Canara Bank₹20 LakhSatisfied

Total charge records: 6 View all charges

MSME Payment Delays by Texas Pharmaceuticals Private Limited

Texas Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 6 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 6)

SupplierAmount dueDue sinceReported on
Saphnix Lifesciences••••••••••••
Sunvet Pharma Private Limited••••••••••••
GG Nutritions••••••••••••
MMG Healthcare••••••••••••
Shervotech Pharmaceuicals••••••••••••
Premium access

Full MSME payment history

Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.

  • Every reported supplier due
  • Amounts and due dates
  • Reasons given in each return
  • Period-by-period history

Verified entity values are shown only after access is granted.

Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.

Employees and EPFO Compliance at Texas Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Texas Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Texas Pharmaceuticals Private Limited

Texas Pharmaceuticals Private Limited has 6 board changes on record since 2011: 4 appointments and 2 cessations. The latest: Arvind Mann was appointed as Director on 08 Aug 2014.

AGM
Texas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 03 Aug 2023 via Charge ID 100787923 with Canara Bank was fully satisfied on 15 Sep 2025.
Charges
A charge with Canara Bank amounted to Rs. 0.46 Cr with Charge ID 101156993 was registered on 25 Aug 2025.
Filing
Texas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Canara Bank amounted to Rs. 0.60 Cr with Charge ID 101048545 was registered on 11 Feb 2025.
Charges
A charge with Canara Bank of Rs. 2.50 Cr registered on 08 Mar 2013 with Charge ID 10457550 was modified on 30 Nov 2024.
Charges
A charge with Canara Bank amounted to Rs. 0.13 Cr with Charge ID 100787923 was registered on 03 Aug 2023.
Charges
A charge registered on 18 Aug 2016 via Charge ID 100048081 with Others was fully satisfied on 21 Jul 2022.
Charges
A charge registered on 18 Nov 2016 via Charge ID 100065559 with Canara Bank was fully satisfied on 28 Jun 2021.
Charges
A charge with Canara Bank amounted to Rs. 0.20 Cr with Charge ID 100065559 was registered on 18 Nov 2016.
Charges
A charge with Others amounted to Rs. 1.65 Cr with Charge ID 100048081 was registered on 18 Aug 2016.
Appointed
Arvind Mann was appointed as Director.

7 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Texas Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Texas Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Texas Pharmaceuticals Private Limited

Texas Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
06AADCT9364J1ZWHaryanaActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Texas Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Texas Pharmaceuticals Private Limited

Texas Pharmaceuticals is an active private limited company based in Karnal, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 July 2011 (15+ years old) and is registered under CIN U24232HR2011PTC043450.

Texas Pharmaceuticals reported revenue of ₹11.03 Cr for FY 2025 (up 3% YoY).

Texas Pharmaceuticals has 4 current directors:

Texas Pharmaceuticals reported a net profit of ₹6.29 Lakh (net margin 0.6%) and EBITDA of ₹41.98 Lakh (EBITDA margin 3.8%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Texas Pharmaceuticals is -3% over three years and -3% over five years. In the latest year (FY 2025) revenue rose 3%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Texas Pharmaceuticals is 06AADCT9364J1ZW, registered in Haryana.

The CIN (Corporate Identification Number) of Texas Pharmaceuticals is U24232HR2011PTC043450. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Texas Pharmaceuticals has 3 court cases on record: 2 filed by the company and 1 filed against it. 2 are pending.

Texas Pharmaceuticals was incorporated on 19 July 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Texas Pharmaceuticals by revenue are RN Chemicals & Pharmaceutical Private Limited, Pilco Healthcare Private Limited, Osper Formulations Private Limited, Gryff Pharmaceuticals Private Limited, Cisen Pharmaceuticals India Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).

Arvind Mann was appointed as Director on 08 Aug 2014. Ashok Kumar was appointed as Director on 08 Aug 2014. Madhu ceased to be Additional Director on 29 Sep 2012. Texas Pharmaceuticals has 6 board changes on record in total.

Yes, Texas Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-HR-10-0001514).

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available